ADESSO BIOPRODUCTS AS

1630 GAMLE FREDRIKSTAD

Finances

Share Ownership

Return on Equity

13,76 %

Current Ratio

1,54

Debt-to-Equity Ratio

0,02

Key figures (NOK)	2022	2021	2020	2019
Revenue	105 368 000	74 976 000	59 179 000	62 633 000
Net Income	5 206 000	3 932 000	2 884 000	3 687 000
Total Assets	80 634 000	81 184 000	57 302 000	59 753 000
Total Equity	37 847 000	32 641 000	28 709 000	25 825 000

Income (NOK)	2022	2021	2020	2019
Revenue	105 368 000	74 976 000	59 179 000	62 633 000
Expenditure	98 344 000	69 825 000	55 010 000	57 528 000
Operating Profit	7 024 000	5 152 000	4 169 000	5 106 000
Financial Income	263 000	258 000	241 000	104 000
Financial Costs	604 000	355 000	703 000	472 000
Financial Balance	−341 000	−97 000	−462 000	−368 000
Earnings Before Tax	6 683 000	5 055 000	3 707 000	4 738 000
Tax	1 477 000	1 124 000	822 000	1 051 000
Net Income	5 206 000	3 932 000	2 884 000	3 687 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	16 128 000	16 866 000	18 650 000	19 065 000
Total Current Assets	64 506 000	64 318 000	38 652 000	40 688 000
Total Assets	80 634 000	81 184 000	57 302 000	59 753 000
Total Retained Equity	22 746 000	17 540 000	13 608 000	10 724 000
Total Equity	37 847 000	32 641 000	28 709 000	25 825 000
Total Long-Term Debt	776 000	854 000	922 000	966 000
Total Current Debt	42 012 000	47 689 000	27 671 000	32 963 000
Total Equity and Debt	80 634 000	81 184 000	57 302 000	59 753 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	105 368 000	74 976 000	59 179 000	62 633 000
Other Income	0	0	0	0
Revenue	105 368 000	74 976 000	59 179 000	62 633 000
Cost of Goods Sold	60 177 000	37 474 000	22 617 000	27 389 000
Salary Costs	15 832 000	14 771 000	14 873 000	13 410 000
Depreciation	1 674 000	1 784 000	1 980 000	1 181 000
Impairment	0	0	0	0
Expenditure	98 344 000	69 825 000	55 010 000	57 528 000
Operating Profit	7 024 000	5 152 000	4 169 000	5 106 000
Financial Income	263 000	258 000	241 000	104 000
Financial Costs	604 000	355 000	703 000	472 000
Financial Balance	−341 000	−97 000	−462 000	−368 000
Dividends	0	0	0	0
Net Income	5 206 000	3 932 000	2 884 000	3 687 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	8 259 000	8 465 000	8 672 000	9 040 000
Machinery and Plant Facilities	0	0	0	0
Fixtures	7 870 000	8 401 000	9 978 000	10 025 000
Total Tangible Assets	16 128 000	16 866 000	18 650 000	19 065 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	16 128 000	16 866 000	18 650 000	19 065 000
Stock	3 433 000	3 589 000	3 687 000	0
Total Investments	0	0	0	0
Cash, Bank	21 652 000	13 287 000	5 435 000	6 457 000
Total Current Assets	64 506 000	64 318 000	38 652 000	40 688 000
Total Assets	80 634 000	81 184 000	57 302 000	59 753 000
Total Equity	37 847 000	32 641 000	28 709 000	25 825 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	776 000	854 000	922 000	966 000
Creditors	9 451 000	7 095 000	7 718 000	3 801 000
Unpaid Taxes	29 526 000	37 604 000	17 701 000	27 006 000
Dividends	0	0	0	0
Other Current Debt	1 480 000	1 798 000	1 386 000	1 275 000
Total Current Debt	42 012 000	47 689 000	27 671 000	32 963 000
Total Equity and Debt	80 634 000	81 184 000	57 302 000	59 753 000

Financial indicators	2022	2021	2020	2019
Return on Equity	13,76 %	12,05 %	10,05 %	14,28 %
Debt-to-Equity Ratio	0,02	0,03	0,03	0,04
Operating Profit Margin	6,67 %	6,87 %	7,04 %	8,15 %
Current Ratio	1,54	1,35	1,4	1,23
Quick Ratio	1,67	1,46	1,61	1,23
Equity Ratio	0,47	0,4	0,5	0,43
Gross Profit Margin	42,89 %	50,02 %	61,78 %	56,27 %